No, there are great companies, with successful trials in the cell therapy sector that are undervalued. Wall greet has a tendency to do so except where there is artificial optimism and a bubble generated as in the Car-T space.
This also has not yet been able to be publicized and those with effectively early information, are in an unusually good position, but it is too bad they are so greedy they are trying to talk the price down to re-up with more shares for the same $$.
The behavior is obvious and there are likely large traders trying to do the same, pissed off that they did not buy at .14, but also having had many other trading activities in that period, they are greedy. They want what every other long has, but at the same or similar cheap prices, without having had to hold.
Market Data 
Markets 
AI
